Abstract

Barley have a component of soluble fiber called β-glucan which have β-(1→3) and β-(1→4)-linkages. Studies on the physiological functions of barley have been rapidly increasing in terms of the cholesterol-lowering effect, serum glucose and insulin normalization including the second meal effects, decreased body fat accumulation, and appetite control. It has been scientifically proven that the soluble dietary fiber in barley, β-glucan, might reduce the risk of cardiovascular disease (CVD). The Food and Drug Administration (FDA) has stated that daily intakes of 3 g or more of soluble fiber (β-glucan) in barley may reduce the risk of heart disease by its ability to lower total cholesterol and LDL-cholesterol. The European Food Safety Authority (EFSA) supported the following health claim for barley β-glucan: 1) maintenance of normal blood LDL-cholesterol concentrations, 2) reduction of post-prandial glycemic responses, and 3) digestive function (normal stool frequency). Recent clinical studies have suggested that the consumption of barley and its products might reduce many risk factors associated with the metabolic syndrome, namely diabetes and dyslipidemia. In our inter vention study in Japanese men and women, the consumption of high β-glucan barley reduced waist circumstaznce and visceral fat area. This review presents recent information about the health function of barley β-glucan.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.